Research has identified a small molecule compound that can activate the Wnt pathway in non-Wnt subtypes of medulloblastoma, making these aggressive forms of cancer more responsive to therapies. The work also found the Wnt pathway, which has historically been considered cancer-promoting, to function as a cancer inhibitor in certain contexts.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/08/200828081024.htm
No comments:
Post a Comment